Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Katherine Hewitt is active.

Publication


Featured researches published by Katherine Hewitt.


Toxicology in Vitro | 2010

Cigarette smoke total particulate matter increases mucous secreting cell numbers in vitro: a potential model of goblet cell hyperplasia.

Linsey Haswell; Katherine Hewitt; David Thorne; Audrey Richter; Marianna Gaça

Cigarette smoking is associated with chronic obstructive pulmonary disease (COPD)--a term encompassing chronic lung inflammation, chronic bronchitis and emphysema. Goblet cell hyperplasia is a characteristic feature of the lung epithelium in COPD patients contributing to the overproduction of airway mucus, including mucin MUC5AC. Using an in vitro model of differentiated lung epithelium we have investigated morphological and cellular changes in response to interleukin (IL)-13 (2.5-20 ng/ml), cigarette smoke total particulate matter (TPM; 0.31-20 microg/ml) and three mainstream cigarette smoke constituents: acrolein, formaldehyde and acetaldehyde (all at 0.001-1 microM) over 28 days during differentiation (agents replaced daily Monday-Friday). Control cultures of human bronchial epithelial cells (HBECs) underwent mucociliary differentiation producing a columnar epithelium containing goblet, ciliated and basal cells. Non-cytotoxic doses of IL-13 induced a significant increase in the percentage of MUC5AC positive cells. Using both flow cytometry and immunocytochemical techniques for identification of MUC5AC positive cells, TPM treatment induced an increase in MUC5AC positive cells, becoming maximal at 5 microg/ml. Acrolein treatment also increased the percentage of MUC5AC positive cells. However, formaldehyde or acetaldehyde had little effect. This study demonstrates that lung toxicants can induce a profound effect on cellular differentiation in an in vitro model of the human lung epithelium.


Toxicology in Vitro | 2015

Evaluation of an air–liquid interface cell culture model for studies on the inflammatory and cytotoxic responses to tobacco smoke aerosols

David Azzopardi; Linsey Haswell; Geoff Foss-Smith; Katherine Hewitt; Nathan Asquith; Sarah Corke; Gary Phillips

In vitro toxicological studies for tobacco product assessment have traditionally been undertaken using the particulate phase of tobacco smoke. However, this does not truly reflect exposure conditions that occur in smokers. Thus in vitro cell culture systems are required in which cells are exposed to tobacco whole smoke (WS) at the air-liquid interface (ALI). In this study bronchial epithelial cells were cultured on semi-permeable membranes, transitioned to the ALI and the robustness and sensitivity of the cells to tobacco WS and vapour phase (VP) assessed. Although no effect of air exposure was observed on cell viability, IL-6 and IL-8 release was increased. Exposure to WS resulted in a significant dose dependent decrease in cell viability and a significant non-dose dependent increase in inflammatory mediator secretion. The VP was found to contribute approximately 90% of the total cytotoxicity derived from WS. The cell culture system was also able to differentiate between two smoking regimens and was sensitive to passage number with increased inflammatory mediator secretion and lower cell viability observed in cell cultures of low passage number following WS exposure. This simple cell culture system may facilitate studies on the toxicological impact of future tobacco products and nicotine delivery devices.


Toxicology in Vitro | 2011

CYP1A1/1B1 and CYP2A6/2A13 activity is conserved in cultures of differentiated primary human tracheobronchial epithelial cells

Nik Newland; Andrew Baxter; Katherine Hewitt; Emmanuel Minet

BACKGROUND The respiratory tract is the primary route of exposure to inhaled toxicants such as environmental pollutants and tobacco smoke. Metabolic activation of xenobiotics is a contributor to the onset of lung diseases. Enzymes such as CYP1A1/1B1 and CYP2A6/2A13 activate polycyclic aromatic hydrocarbons and nitrosamines, respectively. Yet, few in vitro models retaining both adequate morphology and metabolic activities are currently available to investigate smoke toxicity. OBJECTIVE We characterised the expression and activity of the toxicologically relevant metabolic enzymes CYP1A1/1B1 and CYP2A6/2A13 in polarised primary tracheobronchial epithelial cells cultured at the air-liquid interface. Metabolic activity was compared with NCI-H292 and A549, two commonly used lung epithelial cell models. RESULTS We report that CYP activity and inducibility is conserved in polarised primary tracheobronchial epithelial cells for 7- and 28-days cultured at the air-liquid interface. In comparison, NCI-H292 cells did not show CYP2A6/2A13 activity whilst A549 cells did not display significant metabolic activity for CYP1A1/1B1 or CYP2A6/2A13. CONCLUSION Primary tracheobronchial epithelial cells retain both a polarised morphology and significant metabolic activity over a prolonged period of time. On the other hand, although A549 cells and NCI-H292 cells have been extensively used as lung models for toxicological assessment, they lack critical metabolic activation capability.


Redox biology | 2017

Cigarette smoke extract counteracts atheroprotective effects of high laminar flow on endothelial function

Sindy Giebe; Natalia Cockcroft; Katherine Hewitt; Melanie Brux; Anja Hofmann; Henning Morawietz; Coy Brunssen

Tobacco smoking and hemodynamic forces are key stimuli in the development of endothelial dysfunction and atherosclerosis. High laminar flow has an atheroprotective effect on the endothelium and leads to a reduced response of endothelial cells to cardiovascular risk factors compared to regions with disturbed or low laminar flow. We hypothesize that the atheroprotective effect of high laminar flow could delay the development of endothelial dysfunction caused by cigarette smoking. Primary human endothelial cells were stimulated with increasing dosages of aqueous cigarette smoke extract (CSEaq). CSEaq reduced cell viability in a dose-dependent manner. The main mediator of cellular adaption to oxidative stress, nuclear factor erythroid 2-related factor 2 (NRF2) and its target genes heme oxygenase (decycling) 1 (HMOX1) or NAD(P)H quinone dehydrogenase 1 (NQO1) were strongly increased by CSEaq in a dose-dependent manner. High laminar flow induced elongation of endothelial cells in the direction of flow, activated the AKT/eNOS pathway, increased eNOS expression, phosphorylation and NO release. These increases were inhibited by CSEaq. Pro-inflammatory adhesion molecules intercellular adhesion molecule-1 (ICAM1), vascular cell adhesion molecule-1 (VCAM1), selectin E (SELE) and chemokine (C-C motif) ligand 2 (CCL2/MCP-1) were increased by CSEaq. Low laminar flow induced VCAM1 and SELE compared to high laminar flow. High laminar flow improved endothelial wound healing. This protective effect was inhibited by CSEaq in a dose-dependent manner through the AKT/eNOS pathway. Low as well as high laminar flow decreased adhesion of monocytes to endothelial cells. Whereas, monocyte adhesion was increased by CSEaq under low laminar flow, this was not evident under high laminar flow. This study shows the activation of major atherosclerotic key parameters by CSEaq. Within this process, high laminar flow is likely to reduce the harmful effects of CSEaq to a certain degree. The identified molecular mechanisms might be useful for development of alternative therapy concepts.


F1000Research | 2014

The cytotoxic and inflammatory response of bronchial epithelial cells to cigarette whole smoke and vapour phase at the air-liquid interface

David Azzopardi; Linsey Haswell; Geoff Foss-Smith; Katherine Hewitt; Sarah Corke; Gary Phillips

INTRODUCTION Prolonged cigarette smoke exposure is known to be a causative factor in the development of cardiovascular disease, chronic obstructive pulmonary disease (COPD) and cancer (1). Cigarette whole smoke (WS) is a complex aerosol, made up of approximately 5700 identified constituents distributed in the particulate and vapour phases (VP), with the latter constituting ~95% by weight (2). The role of each component of cigarette smoke in the development of smoking related diseases is largely unknown, however, exposure to both phases and the retention of smoke particulate has been implicated to contribute to smoking related injury and disease (1,3).


F1000Research | 2014

The use of human sera as a novel exposure system for in vitro models examining the effects of cigarette smoking on cardiovascular disease

Ian M. Fearon; Karina McQuillan; Mark Taylor; Tony Carr; Olivia Mayland; Katherine Hewitt; Karsta Luettich; Frazer Lowe; Christopher Proctor

Commonly used exposure agents for in vitro models include extracts of particulate matter and smoke vapours. However, these may not realistically represent cardiovascular system exposure to cigarette smoke. Here we explore the use of smokers’ sera as a more relevant exposure agent in studies monitoring a number of cardiovascular disease endpoints in cultured endothelial cells exposed to sera. The use of human sera as a novel exposure system for in vitro models examining the effects of cigarette smoking on cardiovascular disease.


F1000Research | 2014

The inflammatory response of the H292 lung epithelial model to cigarette smoke particulate generated using different smoking regimes and reduced toxicant prototypes

Sarah Corke; Geoff Foss-Smith; Katherine Hewitt; Linsey Haswell; David Azzopardi; Gary Phillips

Ar se n ic B e n zo (a )p yre n e Cd m u m Ch V I The inflammatory response of the H292 lung epithelial model to cigarette smoke particulate generated using different smoking regimes and reduced toxicant prototypes Sarah Corke, Geoff Foss-Smith, Katherine Hewitt, Linsey Haswell, David Azzopardi and Gary Phillips British American Tobacco, Group Research & Development, Regents Park Road, Southampton, SO15 8TL, UK Corresponding author: [email protected]


Food and Chemical Toxicology | 2017

A novel hybrid tobacco product that delivers a tobacco flavour note with vapour aerosol (Part 2): In vitro biological assessment and comparison with different tobacco-heating products

Damien Breheny; Jason Adamson; David Azzopardi; Andrew Baxter; Emma Bishop; Tony Carr; Ian Crooks; Katherine Hewitt; Tomasz Jaunky; Sophie Larard; Frazer Lowe; Oluwatobiloba Oke; Mark Taylor; Simone Santopietro; David Thorne; Benjamin Zainuddin; Marianna Gaça; Chuan Liu; James Murphy; Christopher Proctor


Toxicology Letters | 2017

A comparative assessment of e-cigarette aerosols and cigarette smoke on in vitro endothelial cell migration

Mark Taylor; Tomasz Jaunky; Katherine Hewitt; Damien Breheny; Frazer Lowe; Ian M. Fearon; Marianna Gaça


Cardiovascular Research | 2018

P545Impact of cigarette smoke, next generation tobacco and nicotine products on the cytotoxic, oxidative and pro-inflammatory status of THP-1 cells

Coy Brunssen; Sindy Giebe; A Hofmann; Melanie Brux; Katherine Hewitt; Frazer Lowe; Henning Morawietz

Collaboration


Dive into the Katherine Hewitt's collaboration.

Top Co-Authors

Avatar

Frazer Lowe

British American Tobacco

View shared research outputs
Top Co-Authors

Avatar

Linsey Haswell

British American Tobacco

View shared research outputs
Top Co-Authors

Avatar

Mark Taylor

British American Tobacco

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Marianna Gaça

British American Tobacco

View shared research outputs
Top Co-Authors

Avatar

Tony Carr

British American Tobacco

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Sarah Corke

British American Tobacco

View shared research outputs
Top Co-Authors

Avatar

Coy Brunssen

Dresden University of Technology

View shared research outputs
Researchain Logo
Decentralizing Knowledge